KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Bionano Genomics (BNGO) Preferred Shares Issued (2017 - 2019)

Bionano Genomics (BNGO) has disclosed Preferred Shares Issued for 2 consecutive years, with $2.4 million as the latest value for Q1 2019.

Quarterly Preferred Shares Issued changed N/A to $2.4 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $3.9 million through Mar 2019, changed N/A year-over-year, with the annual reading at $17.6 million for FY2017, N/A changed from the prior year.
Preferred Shares Issued hit $2.4 million in Q1 2019 for Bionano Genomics, up from $1.5 million in the prior quarter.
In the past five years, Preferred Shares Issued ranged from a high of $2.4 million in Q1 2019 to a low of $1.5 million in Q4 2017.